(Q48174974)

English

Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

6

object named as

Agid Y

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

author name string

Marin C

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

Ruberg M

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

Jimenez A

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

Raisman-Vozari R

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

Tolosa E

7

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

Hirsch EC

8

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

73

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

344-352

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Electrophysiological study of the excitatory parafascicular projection to the subthalamic nucleus and evidence for ipsi- and contralateral controls

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

The current model of basal ganglia organization under scrutiny

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Quisqualate- and NMDA-sensitive [3H]glutamate binding in primate brain.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730344.X

21 January 2018

Identifiers

10.1046/J.1471-4159.1999.0730344.X

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10386987

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48174974&oldid=2188659603"